APO Research
Talk to an analyst

APO RESEARCH · REPORT

Procaine

Compare research editions
View pricing & licenses

Selected research

Industry Research

Procaine Industry Research Report 2026

19 December 2025146 pages

Choose your research edition.

Industry ResearchProcaine Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Procaine Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Procaine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Procaine Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Procaine Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Procaine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Procaine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Procaine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Procaine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Procaine include Ardeapharma, Bel Mar Laboratories, Bristol-Myers Squibb, Consolidated Pharmaceutical, Elkins Sinn, Fuso Pharmaceutical, Grindeks, Hevert-Arzneimittel and Hikari Seiyaku, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Procaine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Procaine Market by Company

Ardeapharma

Bel Mar Laboratories

Bristol-Myers Squibb

Consolidated Pharmaceutical

Elkins Sinn

Fuso Pharmaceutical

Grindeks

Hevert-Arzneimittel

Hikari Seiyaku

Köhler-Pharma

Richter Pharma

RNP Pharmaceuticals

Stada

SÜDmedica Gmbh

Tbilchempharma

Teofarma

Towa Yakuhin

Watson Laboratories

Bayer

Pfizer

Eli Lilly and Company

Procaine Segment by Type

Injection

Powder

Procaine Segment by Application

Hospital

Drug Store

On-line

Procaine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Procaine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Procaine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Procaine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Procaine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Procaine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Procaine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Procaine Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Procaine Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Procaine Sales Market Share by Manufacturers (2021-2026) Table 8. Global Procaine Revenue of Manufacturers (2021-2026) Table 9. Global Procaine Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Procaine Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Procaine Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Procaine, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Procaine, Product Type & Application Table 14. Global Procaine Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Procaine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Ardeapharma Company Information Table 19. Ardeapharma Business Overview Table 20. Ardeapharma Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Ardeapharma Procaine Product Portfolio Table 22. Ardeapharma Recent Developments Table 23. Bel Mar Laboratories Company Information Table 24. Bel Mar Laboratories Business Overview Table 25. Bel Mar Laboratories Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Bel Mar Laboratories Procaine Product Portfolio Table 27. Bel Mar Laboratories Recent Developments Table 28. Bristol-Myers Squibb Company Information Table 29. Bristol-Myers Squibb Business Overview Table 30. Bristol-Myers Squibb Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Bristol-Myers Squibb Procaine Product Portfolio Table 32. Bristol-Myers Squibb Recent Developments Table 33. Consolidated Pharmaceutical Company Information Table 34. Consolidated Pharmaceutical Business Overview Table 35. Consolidated Pharmaceutical Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Consolidated Pharmaceutical Procaine Product Portfolio Table 37. Consolidated Pharmaceutical Recent Developments Table 38. Elkins Sinn Company Information Table 39. Elkins Sinn Business Overview Table 40. Elkins Sinn Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Elkins Sinn Procaine Product Portfolio Table 42. Elkins Sinn Recent Developments Table 43. Fuso Pharmaceutical Company Information Table 44. Fuso Pharmaceutical Business Overview Table 45. Fuso Pharmaceutical Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Fuso Pharmaceutical Procaine Product Portfolio Table 47. Fuso Pharmaceutical Recent Developments Table 48. Grindeks Company Information Table 49. Grindeks Business Overview Table 50. Grindeks Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Grindeks Procaine Product Portfolio Table 52. Grindeks Recent Developments Table 53. Hevert-Arzneimittel Company Information Table 54. Hevert-Arzneimittel Business Overview Table 55. Hevert-Arzneimittel Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Hevert-Arzneimittel Procaine Product Portfolio Table 57. Hevert-Arzneimittel Recent Developments Table 58. Hikari Seiyaku Company Information Table 59. Hikari Seiyaku Business Overview Table 60. Hikari Seiyaku Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Hikari Seiyaku Procaine Product Portfolio Table 62. Hikari Seiyaku Recent Developments Table 63. Köhler-Pharma Company Information Table 64. Köhler-Pharma Business Overview Table 65. Köhler-Pharma Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Köhler-Pharma Procaine Product Portfolio Table 67. Köhler-Pharma Recent Developments Table 68. Richter Pharma Company Information Table 69. Richter Pharma Business Overview Table 70. Richter Pharma Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Richter Pharma Procaine Product Portfolio Table 72. Richter Pharma Recent Developments Table 73. RNP Pharmaceuticals Company Information Table 74. RNP Pharmaceuticals Business Overview Table 75. RNP Pharmaceuticals Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. RNP Pharmaceuticals Procaine Product Portfolio Table 77. RNP Pharmaceuticals Recent Developments Table 78. Stada Company Information Table 79. Stada Business Overview Table 80. Stada Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Stada Procaine Product Portfolio Table 82. Stada Recent Developments Table 83. SÜDmedica Gmbh Company Information Table 84. SÜDmedica Gmbh Business Overview Table 85. SÜDmedica Gmbh Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. SÜDmedica Gmbh Procaine Product Portfolio Table 87. SÜDmedica Gmbh Recent Developments Table 88. Tbilchempharma Company Information Table 89. Tbilchempharma Business Overview Table 90. Tbilchempharma Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Tbilchempharma Procaine Product Portfolio Table 92. Tbilchempharma Recent Developments Table 93. Teofarma Company Information Table 94. Teofarma Business Overview Table 95. Teofarma Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Teofarma Procaine Product Portfolio Table 97. Teofarma Recent Developments Table 98. Towa Yakuhin Company Information Table 99. Towa Yakuhin Business Overview Table 100. Towa Yakuhin Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Towa Yakuhin Procaine Product Portfolio Table 102. Towa Yakuhin Recent Developments Table 103. Watson Laboratories Company Information Table 104. Watson Laboratories Business Overview Table 105. Watson Laboratories Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Watson Laboratories Procaine Product Portfolio Table 107. Watson Laboratories Recent Developments Table 108. Bayer Company Information Table 109. Bayer Business Overview Table 110. Bayer Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Bayer Procaine Product Portfolio Table 112. Bayer Recent Developments Table 113. Pfizer Company Information Table 114. Pfizer Business Overview Table 115. Pfizer Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Pfizer Procaine Product Portfolio Table 117. Pfizer Recent Developments Table 118. Eli Lilly and Company Company Information Table 119. Eli Lilly and Company Business Overview Table 120. Eli Lilly and Company Procaine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Eli Lilly and Company Procaine Product Portfolio Table 122. Eli Lilly and Company Recent Developments Table 123. Global Procaine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 124. Global Procaine Sales by Region (2021-2026) & (K Units) Table 125. Global Procaine Sales Market Share by Region (2021-2026) Table 126. Global Procaine Sales by Region (2027-2032) & (K Units) Table 127. Global Procaine Sales Market Share by Region (2027-2032) Table 128. Global Procaine Revenue by Region (2021-2026) & (US$ Million) Table 129. Global Procaine Revenue Market Share by Region (2021-2026) Table 130. Global Procaine Revenue by Region (2027-2032) & (US$ Million) Table 131. Global Procaine Revenue Market Share by Region (2027-2032) Table 132. North America Procaine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. North America Procaine Sales by Country (2021-2026) & (K Units) Table 134. North America Procaine Sales by Country (2027-2032) & (K Units) Table 135. North America Procaine Revenue by Country (2021-2026) & (US$ Million) Table 136. North America Procaine Revenue by Country (2027-2032) & (US$ Million) Table 137. Europe Procaine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Europe Procaine Sales by Country (2021-2026) & (K Units) Table 139. Europe Procaine Sales by Country (2027-2032) & (K Units) Table 140. Europe Procaine Revenue by Country (2021-2026) & (US$ Million) Table 141. Europe Procaine Revenue by Country (2027-2032) & (US$ Million) Table 142. Asia Pacific Procaine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Asia Pacific Procaine Sales by Country (2021-2026) & (K Units) Table 144. Asia Pacific Procaine Sales by Country (2027-2032) & (K Units) Table 145. Asia Pacific Procaine Revenue by Country (2021-2026) & (US$ Million) Table 146. Asia Pacific Procaine Revenue by Country (2027-2032) & (US$ Million) Table 147. South America Procaine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. South America Procaine Sales by Country (2021-2026) & (K Units) Table 149. South America Procaine Sales by Country (2027-2032) & (K Units) Table 150. South America Procaine Revenue by Country (2021-2026) & (US$ Million) Table 151. South America Procaine Revenue by Country (2027-2032) & (US$ Million) Table 152. Middle East and Africa Procaine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. Middle East and Africa Procaine Sales by Country (2021-2026) & (K Units) Table 154. Middle East and Africa Procaine Sales by Country (2027-2032) & (K Units) Table 155. Middle East and Africa Procaine Revenue by Country (2021-2026) & (US$ Million) Table 156. Middle East and Africa Procaine Revenue by Country (2027-2032) & (US$ Million) Table 157. Global Procaine Sales by Type (2021-2026) & (K Units) Table 158. Global Procaine Sales by Type (2027-2032) & (K Units) Table 159. Global Procaine Sales Market Share by Type (2021-2026) Table 160. Global Procaine Sales Market Share by Type (2027-2032) Table 161. Global Procaine Revenue by Type (2021-2026) & (US$ Million) Table 162. Global Procaine Revenue by Type (2027-2032) & (US$ Million) Table 163. Global Procaine Revenue Market Share by Type (2021-2026) Table 164. Global Procaine Revenue Market Share by Type (2027-2032) Table 165. Global Procaine Price by Type (2021-2026) & (US$/Unit) Table 166. Global Procaine Price by Type (2027-2032) & (US$/Unit) Table 167. Global Procaine Sales by Application (2021-2026) & (K Units) Table 168. Global Procaine Sales by Application (2027-2032) & (K Units) Table 169. Global Procaine Sales Market Share by Application (2021-2026) Table 170. Global Procaine Sales Market Share by Application (2027-2032) Table 171. Global Procaine Revenue by Application (2021-2026) & (US$ Million) Table 172. Global Procaine Revenue by Application (2027-2032) & (US$ Million) Table 173. Global Procaine Revenue Market Share by Application (2021-2026) Table 174. Global Procaine Revenue Market Share by Application (2027-2032) Table 175. Global Procaine Price by Application (2021-2026) & (US$/Unit) Table 176. Global Procaine Price by Application (2027-2032) & (US$/Unit) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Procaine Distributors List Table 180. Procaine Customers List Table 181. Procaine Industry Trends Table 182. Procaine Industry Drivers Table 183. Procaine Industry Restraints Table 184. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Procaine Product Image Figure 5. Global Procaine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Procaine Market Size (2021-2032) & (US$ Million) Figure 7. Global Procaine Sales (2021-2032) & (K Units) Figure 8. Global Procaine Average Price (US$/Unit) & (2021-2032) Figure 9. Injection Product Image Figure 10. Powder Product Image Figure 11. Hospital Product Image Figure 12. Drug Store Product Image Figure 13. On-line Product Image Figure 14. Global Procaine Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Procaine, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Procaine Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Procaine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Procaine Sales by Region in 2025 Figure 20. Global Procaine Revenue by Region in 2025 Figure 21. North America Procaine Market Size by Country in 2025 Figure 22. North America Procaine Sales Market Share by Country (2021-2032) Figure 23. North America Procaine Revenue Market Share by Country (2021-2032) Figure 24. United States Procaine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Procaine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe Procaine Market Size by Country in 2025 Figure 27. Europe Procaine Sales Market Share by Country (2021-2032) Figure 28. Europe Procaine Revenue Market Share by Country (2021-2032) Figure 29. Germany Procaine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France Procaine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. Procaine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy Procaine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Netherlands Procaine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Asia Pacific Procaine Market Size by Country in 2025 Figure 35. Asia Pacific Procaine Sales Market Share by Country (2021-2032) Figure 36. Asia Pacific Procaine Revenue Market Share by Country (2021-2032) Figure 37. China Procaine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Japan Procaine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. South Korea Procaine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. India Procaine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Australia Procaine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. China Taiwan Procaine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Southeast Asia Procaine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Southeast Asia Procaine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South America Procaine Market Size by Country in 2025 Figure 46. South America Procaine Sales Market Share by Country (2021-2032) Figure 47. South America Procaine Revenue Market Share by Country (2021-2032) Figure 48. Mexico Procaine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Brazil Procaine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Argentina Procaine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Colombia Procaine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Middle East and Africa Procaine Market Size by Country in 2025 Figure 53. Middle East and Africa Procaine Sales Market Share by Country (2021-2032) Figure 54. Middle East and Africa Procaine Revenue Market Share by Country (2021-2032) Figure 55. Turkey Procaine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Saudi Arabia Procaine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. UAE Procaine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Global Procaine Sales Market Share by Type (2021-2032) Figure 59. Global Procaine Revenue Market Share by Type (2021-2032) Figure 60. Global Procaine Price (US$/Unit) by Type (2021-2032) Figure 61. Global Procaine Sales Market Share by Application (2021-2032) Figure 62. Global Procaine Revenue Market Share by Application (2021-2032) Figure 63. Global Procaine Price (US$/Unit) by Application (2021-2032) Figure 64. Procaine Value Chain Figure 65. Procaine Production Mode & Process Figure 66. Direct Comparison with Distribution Share Figure 67. Distributors Profiles Figure 68. Procaine Industry Opportunities and Challenges

Scope & coverage.

Types
  • Injection
  • Powder
Applications
  • Hospital
  • Drug Store
  • On-line
Companies covered
  • Ardeapharma
  • Bel Mar Laboratories
  • Bristol-Myers Squibb
  • Consolidated Pharmaceutical
  • Elkins Sinn
  • Fuso Pharmaceutical
  • Grindeks
  • Hevert-Arzneimittel
  • Hikari Seiyaku
  • Köhler-Pharma
  • Richter Pharma
  • RNP Pharmaceuticals
  • Stada
  • SÜDmedica Gmbh
  • Tbilchempharma
  • Teofarma
  • Towa Yakuhin
  • Watson Laboratories
  • Bayer
  • Pfizer
  • Eli Lilly and Company

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Procaine Market Size (2021-2032)
  4. 2.2.2 Global Procaine Sales (2021-2032)
  5. 2.2.3 Global Procaine Market Average Price (2021-2032)
  6. 2.3 Procaine by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Injection
  9. 2.3.3 Powder
  10. 2.4 Procaine by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Drug Store
  14. 2.4.4 On-line
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Procaine Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Procaine Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Procaine Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Procaine Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Procaine Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Procaine, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Procaine, Product Type & Application
  8. 3.8 Global Manufacturers of Procaine, Established Date
  9. 3.9 Global Procaine Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Ardeapharma
  2. 4.1.1 Ardeapharma Company Information
  3. 4.1.2 Ardeapharma Business Overview
  4. 4.1.3 Ardeapharma Procaine Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Ardeapharma Procaine Product Portfolio
  6. 4.1.5 Ardeapharma Recent Developments
  7. 4.2 Bel Mar Laboratories
  8. 4.2.1 Bel Mar Laboratories Company Information
  9. 4.2.2 Bel Mar Laboratories Business Overview
  10. 4.2.3 Bel Mar Laboratories Procaine Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Bel Mar Laboratories Procaine Product Portfolio
  12. 4.2.5 Bel Mar Laboratories Recent Developments
  13. 4.3 Bristol-Myers Squibb
  14. 4.3.1 Bristol-Myers Squibb Company Information
  15. 4.3.2 Bristol-Myers Squibb Business Overview
  16. 4.3.3 Bristol-Myers Squibb Procaine Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Bristol-Myers Squibb Procaine Product Portfolio
  18. 4.3.5 Bristol-Myers Squibb Recent Developments
  19. 4.4 Consolidated Pharmaceutical
  20. 4.4.1 Consolidated Pharmaceutical Company Information
  21. 4.4.2 Consolidated Pharmaceutical Business Overview
  22. 4.4.3 Consolidated Pharmaceutical Procaine Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Consolidated Pharmaceutical Procaine Product Portfolio
  24. 4.4.5 Consolidated Pharmaceutical Recent Developments
  25. 4.5 Elkins Sinn
  26. 4.5.1 Elkins Sinn Company Information
  27. 4.5.2 Elkins Sinn Business Overview
  28. 4.5.3 Elkins Sinn Procaine Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Elkins Sinn Procaine Product Portfolio
  30. 4.5.5 Elkins Sinn Recent Developments
  31. 4.6 Fuso Pharmaceutical
  32. 4.6.1 Fuso Pharmaceutical Company Information
  33. 4.6.2 Fuso Pharmaceutical Business Overview
  34. 4.6.3 Fuso Pharmaceutical Procaine Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Fuso Pharmaceutical Procaine Product Portfolio
  36. 4.6.5 Fuso Pharmaceutical Recent Developments
  37. 4.7 Grindeks
  38. 4.7.1 Grindeks Company Information
  39. 4.7.2 Grindeks Business Overview
  40. 4.7.3 Grindeks Procaine Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Grindeks Procaine Product Portfolio
  42. 4.7.5 Grindeks Recent Developments
  43. 4.8 Hevert-Arzneimittel
  44. 4.8.1 Hevert-Arzneimittel Company Information
  45. 4.8.2 Hevert-Arzneimittel Business Overview
  46. 4.8.3 Hevert-Arzneimittel Procaine Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Hevert-Arzneimittel Procaine Product Portfolio
  48. 4.8.5 Hevert-Arzneimittel Recent Developments
  49. 4.9 Hikari Seiyaku
  50. 4.9.1 Hikari Seiyaku Company Information
  51. 4.9.2 Hikari Seiyaku Business Overview
  52. 4.9.3 Hikari Seiyaku Procaine Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Hikari Seiyaku Procaine Product Portfolio
  54. 4.9.5 Hikari Seiyaku Recent Developments
  55. 4.10 Köhler-Pharma
  56. 4.10.1 Köhler-Pharma Company Information
  57. 4.10.2 Köhler-Pharma Business Overview
  58. 4.10.3 Köhler-Pharma Procaine Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Köhler-Pharma Procaine Product Portfolio
  60. 4.10.5 Köhler-Pharma Recent Developments
  61. 4.11 Richter Pharma
  62. 4.11.1 Richter Pharma Company Information
  63. 4.11.2 Richter Pharma Business Overview
  64. 4.11.3 Richter Pharma Procaine Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Richter Pharma Procaine Product Portfolio
  66. 4.11.5 Richter Pharma Recent Developments
  67. 4.12 RNP Pharmaceuticals
  68. 4.12.1 RNP Pharmaceuticals Company Information
  69. 4.12.2 RNP Pharmaceuticals Business Overview
  70. 4.12.3 RNP Pharmaceuticals Procaine Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 RNP Pharmaceuticals Procaine Product Portfolio
  72. 4.12.5 RNP Pharmaceuticals Recent Developments
  73. 4.13 Stada
  74. 4.13.1 Stada Company Information
  75. 4.13.2 Stada Business Overview
  76. 4.13.3 Stada Procaine Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Stada Procaine Product Portfolio
  78. 4.13.5 Stada Recent Developments
  79. 4.14 SÜDmedica Gmbh
  80. 4.14.1 SÜDmedica Gmbh Company Information
  81. 4.14.2 SÜDmedica Gmbh Business Overview
  82. 4.14.3 SÜDmedica Gmbh Procaine Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 SÜDmedica Gmbh Procaine Product Portfolio
  84. 4.14.5 SÜDmedica Gmbh Recent Developments
  85. 4.15 Tbilchempharma
  86. 4.15.1 Tbilchempharma Company Information
  87. 4.15.2 Tbilchempharma Business Overview
  88. 4.15.3 Tbilchempharma Procaine Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Tbilchempharma Procaine Product Portfolio
  90. 4.15.5 Tbilchempharma Recent Developments
  91. 4.16 Teofarma
  92. 4.16.1 Teofarma Company Information
  93. 4.16.2 Teofarma Business Overview
  94. 4.16.3 Teofarma Procaine Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Teofarma Procaine Product Portfolio
  96. 4.16.5 Teofarma Recent Developments
  97. 4.17 Towa Yakuhin
  98. 4.17.1 Towa Yakuhin Company Information
  99. 4.17.2 Towa Yakuhin Business Overview
  100. 4.17.3 Towa Yakuhin Procaine Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Towa Yakuhin Procaine Product Portfolio
  102. 4.17.5 Towa Yakuhin Recent Developments
  103. 4.18 Watson Laboratories
  104. 4.18.1 Watson Laboratories Company Information
  105. 4.18.2 Watson Laboratories Business Overview
  106. 4.18.3 Watson Laboratories Procaine Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Watson Laboratories Procaine Product Portfolio
  108. 4.18.5 Watson Laboratories Recent Developments
  109. 4.19 Bayer
  110. 4.19.1 Bayer Company Information
  111. 4.19.2 Bayer Business Overview
  112. 4.19.3 Bayer Procaine Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Bayer Procaine Product Portfolio
  114. 4.19.5 Bayer Recent Developments
  115. 4.20 Pfizer
  116. 4.20.1 Pfizer Company Information
  117. 4.20.2 Pfizer Business Overview
  118. 4.20.3 Pfizer Procaine Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Pfizer Procaine Product Portfolio
  120. 4.20.5 Pfizer Recent Developments
  121. 4.21 Eli Lilly and Company
  122. 4.21.1 Eli Lilly and Company Company Information
  123. 4.21.2 Eli Lilly and Company Business Overview
  124. 4.21.3 Eli Lilly and Company Procaine Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Eli Lilly and Company Procaine Product Portfolio
  126. 4.21.5 Eli Lilly and Company Recent Developments
5 Global Procaine Market Scenario by Region
  1. 5.1 Global Procaine Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Procaine Sales by Region: 2021-2032
  3. 5.2.1 Global Procaine Sales by Region: 2021-2026
  4. 5.2.2 Global Procaine Sales by Region: 2027-2032
  5. 5.3 Global Procaine Revenue by Region: 2021-2032
  6. 5.3.1 Global Procaine Revenue by Region: 2021-2026
  7. 5.3.2 Global Procaine Revenue by Region: 2027-2032
  8. 5.4 North America Procaine Market Facts & Figures by Country
  9. 5.4.1 North America Procaine Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Procaine Sales by Country (2021-2032)
  11. 5.4.3 North America Procaine Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Procaine Market Facts & Figures by Country
  15. 5.5.1 Europe Procaine Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Procaine Sales by Country (2021-2032)
  17. 5.5.3 Europe Procaine Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Procaine Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Procaine Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Procaine Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Procaine Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Procaine Market Facts & Figures by Country
  35. 5.7.1 South America Procaine Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Procaine Sales by Country (2021-2032)
  37. 5.7.3 South America Procaine Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.7.7 Colombia
  42. 5.8 Middle East and Africa Procaine Market Facts & Figures by Country
  43. 5.8.1 Middle East and Africa Procaine Market Size by Country: 2021 VS 2025 VS 2032
  44. 5.8.2 Middle East and Africa Procaine Sales by Country (2021-2032)
  45. 5.8.3 Middle East and Africa Procaine Revenue by Country (2021-2032)
  46. 5.8.4 Turkey
  47. 5.8.5 Saudi Arabia
  48. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Procaine Sales by Type (2021-2032)
  2. 6.1.1 Global Procaine Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Procaine Sales Market Share by Type (2021-2032)
  4. 6.2 Global Procaine Revenue by Type (2021-2032)
  5. 6.2.1 Global Procaine Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Procaine Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Procaine Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Procaine Sales by Application (2021-2032)
  2. 7.1.1 Global Procaine Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Procaine Sales Market Share by Application (2021-2032)
  4. 7.2 Global Procaine Revenue by Application (2021-2032)
  5. 7.2.1 Global Procaine Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Procaine Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Procaine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Procaine Value Chain Analysis
  2. 8.1.1 Procaine Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Procaine Production Mode & Process
  5. 8.2 Procaine Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Procaine Distributors
  8. 8.2.3 Procaine Customers
9 Global Procaine Analyzing Market Dynamics
  1. 9.1 Procaine Industry Trends
  2. 9.2 Procaine Industry Drivers
  3. 9.3 Procaine Industry Opportunities and Challenges
  4. 9.4 Procaine Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst